Rating History for Pieris Pharmaceuticals (PIRS) by Baird

More Stocks Rated by Baird | Latest Ratings for PIRS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/13/2020 Madhu Kumar Upgrade Outperform
(Neutral)		 5.00
(N/A)		 2.23
(13.60)		 509.87% Details